Creative Planning
MIRM icon

Creative Planning’s Mirum Pharmaceuticals MIRM Stock Holding History

Creative Planning’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.83M Sell
30,655
-864
-3% -$81.3K ﹤0.01% 1622
2025
Q4 		$2.49M Buy
31,519
+18,775
+147% +$1.35M ﹤0.01% 1544
2025
Q3 		$934K Buy
12,744
+3,527
+38% +$224K ﹤0.01% 2175
2025
Q2 		$469K Sell
9,217
-134
-1% -$5.97K ﹤0.01% 2519
2025
Q1 		$421K Buy
9,351
+1,221
+15% +$57.6K ﹤0.01% 2456
2024
Q4 		$336K Buy
8,130
+1,748
+27% +$72.8K ﹤0.01% 2565
2024
Q3 		$249K Buy
+6,382
New +$255K ﹤0.01% 2685

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Creative Planning's MIRM Position: Q1 2026 in Review

Creative Planning reduced its Mirum Pharmaceuticals (MIRM) stake by 2.7% in Q1 2026, selling an estimated $81.3K and leaving 30,655 shares worth $2.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1622.

Creative Planning first reported a position in MIRM in Q3 2024 and has held it in 7 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Creative Planning held 30,655 shares of Mirum Pharmaceuticals worth $2.83M as of Q1 2026.
  • Creative Planning sold 864 Mirum Pharmaceuticals shares in Q1 2026, an estimated $81.3K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #1622 holding.
  • Creative Planning first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.